Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Navidea Biopharmaceuticals, Inc. (AMEX: NAVB)

 
NAVB Technical Analysis
2
As on 31st Oct 2017 NAVB Share Price closed @ 0.42 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.51 & Buy for SHORT-TERM with Stoploss of 0.41 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NAVB Share Price

Open 0.43 Change Price %
High 0.45 1 Day -0.01 -2.33
Low 0.41 1 Week 0.00 0.00
Close 0.42 1 Month -0.01 -2.33
Volume 282676 1 Year -0.42 -50.00
52 Week High 1.16 | 52 Week Low 0.29
 
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
NGD 3.29 -6.80%
RBY 0.03 -70.00%
LODE 0.12 -7.69%
PBTH 8.23 0.37%
GGR 0.02 100.00%
VTG 0.05 -16.67%
SYRG 8.13 0.87%
GSX 0.02 0.00%
SHZ 0.10 -16.67%
 
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
 
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
LBY 6.84 -25.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
 
 
NAVB
Daily Charts		 NAVB
Intraday Charts		 Whats New @
Bazaartrend		 NAVB
Free Analysis
 
NAVB Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.46
RESISTANCE0.44
SUPPORT0.40
SUPPORT0.38
SUPPORT0.00
SUPPORT0.00
 
NAVB Target for Month July
Share
4th UP TARGET0.96
3rd UP TARGET0.79
2nd UP TARGET0.68
1st UP TARGET0.57
1st DOWN TARGET0.27
2nd DOWN TARGET0.16
3rd DOWN TARGET0.05
4th DOWN TARGET-0.12
 
NAVB Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
NAVB Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
NAVB Other Details
Segment EQ
Market Capital 274868832.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website >
 
NAVB Address
NAVB
 5600 Blazer Parkway
Suite 200
Dublin, OH 43017
United States
Phone: 614-793-7500
Fax: 614-793-7522
 
NAVB Latest News
 
Your Comments and Response on Navidea Biopharmaceuticals, Inc.
 
NAVB Business Profile
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. The companyÂ’s radiopharmaceutical development programs include Lymphoseek Injection, a receptor-targeted small-molecule radiopharmaceutical used in lymphatic mapping procedures, which are performed to evaluate breast cancer and melanoma; Manocept platform to target the CD206 mannose receptor expressed on macrophages; and NAV4694, an Fluorine-18 radiolabeled positron emission tomography imaging agent, which is used as an aid in the diagnosis of patients with signs or symptoms of cognitive impairment, such as AlzheimerÂ’s disease. Its radiopharmaceutical development programs also comprise NAV5001, an Iodine-123 radiolabeled single photon emission computed tomography imaging agent that is used as an aid in the diagnosis of ParkinsonÂ’s disease and other movement disorders with potential use as a diagnostic aid in dementia; and NAV1800, a radiolabeled monoclonal antibody that is developed as a diagnostic aid for use during surgery to help surgeons locate occult or metastatic cancer, primarily colorectal cancer. Navidea Biopharmaceuticals, Inc. has research and development agreements with University of California, AstraZeneca AB, Alseres Pharmaceuticals, Inc., and The Ohio State University. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was founded in 1983 and is headquartered in Dublin, Ohio.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service